SI2968529T1 - Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo - Google Patents

Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo

Info

Publication number
SI2968529T1
SI2968529T1 SI201431687T SI201431687T SI2968529T1 SI 2968529 T1 SI2968529 T1 SI 2968529T1 SI 201431687 T SI201431687 T SI 201431687T SI 201431687 T SI201431687 T SI 201431687T SI 2968529 T1 SI2968529 T1 SI 2968529T1
Authority
SI
Slovenia
Prior art keywords
manufacture
oral desensitization
peanut
formulations
peanut formulations
Prior art date
Application number
SI201431687T
Other languages
English (en)
Slovenian (sl)
Inventor
Bryan Walser
Howard V. Raff
Original Assignee
Aimmune Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2968529(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aimmune Therapeutics, Inc. filed Critical Aimmune Therapeutics, Inc.
Publication of SI2968529T1 publication Critical patent/SI2968529T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
SI201431687T 2013-03-14 2014-03-12 Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo SI2968529T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
EP14776121.7A EP2968529B1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization
PCT/US2014/024401 WO2014159607A1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization

Publications (1)

Publication Number Publication Date
SI2968529T1 true SI2968529T1 (sl) 2021-03-31

Family

ID=51528061

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431687T SI2968529T1 (sl) 2013-03-14 2014-03-12 Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo

Country Status (19)

Country Link
US (5) US9198869B2 (https=)
EP (3) EP3998080A1 (https=)
JP (3) JP6752140B2 (https=)
CN (2) CN109125283A (https=)
AU (5) AU2014240404B2 (https=)
BR (1) BR112015021756B1 (https=)
CA (1) CA2903229A1 (https=)
DK (2) DK3482771T3 (https=)
ES (2) ES2826224T3 (https=)
FI (2) FI3482771T3 (https=)
FR (1) FR23C1026I2 (https=)
HU (1) HUE051831T2 (https=)
MX (1) MX2015010315A (https=)
NL (1) NL301236I2 (https=)
NO (1) NO2023027I1 (https=)
PL (1) PL2968529T3 (https=)
PT (1) PT2968529T (https=)
SI (1) SI2968529T1 (https=)
WO (1) WO2014159607A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
CN109125283A (zh) * 2013-03-14 2019-01-04 艾慕恩治疗公司 用于口服脱敏的花生制剂的制备
EP3185900A4 (en) 2014-08-25 2018-05-02 Aimmune Therapeutics, Inc. Egg protein formulations and methods of manufacture thereof
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
KR20170117562A (ko) 2015-02-20 2017-10-23 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 혼합 알레르겐 조성물 및 그의 사용 방법
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂a及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
WO2018104691A1 (en) * 2016-12-05 2018-06-14 Reacta Biotech Limited Oral food challenge meal formulations
JP2020514306A (ja) * 2017-01-13 2020-05-21 アイミューン セラピューティクス,インコーポレイテッド 経口免疫療法用のナッツ粉および製剤の製造方法
AU2017279647B2 (en) 2017-02-15 2022-05-26 Euroimmun Medizinische Labordiagnostika Ag An improved assay for the diagnosis of peanut allergy
WO2019018529A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. METHODS OF MAKING MIXED ALLERGEN COMPOSITIONS
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
AU2019210146A1 (en) 2018-01-16 2020-09-03 Tel Hashomer Medical Research Infrastructure And Services Ltd. Treatment and prevention of seed allergies
EP3829632A4 (en) 2018-07-27 2022-05-04 Société des Produits Nestlé S.A. SYSTEMS AND METHODS FOR DELIVERING UNIT DOSES OF ORAL IMMUNOTHERAPY
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
AU2019401576A1 (en) * 2018-12-17 2021-06-24 Société des Produits Nestlé S.A. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
US12226448B2 (en) 2018-12-20 2025-02-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
AU2020213085A1 (en) 2019-01-23 2021-08-12 Société des Produits Nestlé S.A. Methods for making mixed allergen compositions
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
MX2022001568A (es) * 2019-08-08 2022-03-02 Evonik Operations Gmbh Procedimiento de preparacion de una forma de dosificacion solida y un lubricante.
EP4061753A4 (en) * 2019-11-20 2023-12-13 Société des Produits Nestlé S.A. METHODS AND SYSTEMS FOR MANAGING THE DISTRIBUTION AND PROCESSING OF AN ORAL IMMUNOTHERAPY DRUG FOR FOOD ALLERGY
KR20220119076A (ko) * 2019-12-23 2022-08-26 프로타 테라퓨틱스 피티와이 엘티디 약학적 조성물
WO2022003604A1 (en) 2020-07-01 2022-01-06 Société des Produits Nestlé S. A. Determining medical staffing for oral immunotherapy
EP4274609A1 (en) 2021-01-08 2023-11-15 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
AU2023253754A1 (en) 2022-04-11 2024-10-17 Alk-Abelló A/S Peanut allergen composition

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
AU1589492A (en) 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
AU2065801A (en) 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
AU1951001A (en) * 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
EP1599185A1 (en) * 2003-02-28 2005-11-30 Alk-Abello A/S Dosage form having a saccharide matrix
EP1734975B1 (en) * 2004-03-19 2015-06-10 Herbs Spring, LLC Herbal therapy for the treatment of food allergy
BRPI0520821A2 (pt) 2005-12-28 2009-06-30 Teva Pharma formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
BRPI0921507A2 (pt) 2008-11-19 2016-01-19 Avantor Performance Mat Inc composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo
US8399519B2 (en) 2008-12-19 2013-03-19 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) * 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es) * 2010-06-30 2012-10-17 Novartis Ag Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
US20140207105A1 (en) * 2011-08-31 2014-07-24 Perosphere, Inc. Methods for Effectively and Rapidly Desensitizing Allergic Patients
WO2013087119A1 (en) 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
CN109125283A (zh) 2013-03-14 2019-01-04 艾慕恩治疗公司 用于口服脱敏的花生制剂的制备
EP3185900A4 (en) 2014-08-25 2018-05-02 Aimmune Therapeutics, Inc. Egg protein formulations and methods of manufacture thereof
JP2020514306A (ja) 2017-01-13 2020-05-21 アイミューン セラピューティクス,インコーポレイテッド 経口免疫療法用のナッツ粉および製剤の製造方法
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy

Also Published As

Publication number Publication date
FIC20230022I1 (fi) 2023-07-04
EP3482771B1 (en) 2023-01-18
JP6752140B2 (ja) 2020-09-09
ES2826224T3 (es) 2021-05-17
US20200129378A1 (en) 2020-04-30
PT2968529T (pt) 2020-11-10
JP2016512537A (ja) 2016-04-28
AU2016231523A1 (en) 2016-10-06
BR112015021756A8 (pt) 2019-11-19
CN105101994A (zh) 2015-11-25
CN109125283A (zh) 2019-01-04
BR112015021756B1 (pt) 2023-01-10
ES2940686T3 (es) 2023-05-10
US11141352B2 (en) 2021-10-12
MX2015010315A (es) 2016-04-13
HK1217660A1 (zh) 2017-01-20
AU2020202685A1 (en) 2020-05-14
AU2020202685B2 (en) 2022-01-20
US9198869B2 (en) 2015-12-01
AU2014240404B2 (en) 2016-07-21
FR23C1026I1 (fr) 2023-10-06
CN105101994B (zh) 2018-10-12
NO2023027I1 (no) 2023-07-06
DK2968529T3 (da) 2020-10-12
JP7454519B2 (ja) 2024-03-22
EP3998080A1 (en) 2022-05-18
US10449118B2 (en) 2019-10-22
EP3482771A1 (en) 2019-05-15
AU2016231523B2 (en) 2018-05-31
PL2968529T3 (pl) 2021-04-19
AU2014240404A1 (en) 2015-09-17
AU2022201858A1 (en) 2022-04-07
DK3482771T3 (da) 2023-03-20
JP6891205B2 (ja) 2021-06-18
EP2968529A4 (en) 2016-10-05
FR23C1026I2 (fr) 2024-07-26
US20180042816A1 (en) 2018-02-15
US20230120350A1 (en) 2023-04-20
US20160030289A1 (en) 2016-02-04
HUE051831T2 (hu) 2021-03-29
EP2968529A1 (en) 2016-01-20
AU2018222980A1 (en) 2018-09-20
FI3482771T3 (fi) 2023-04-03
CA2903229A1 (en) 2014-10-02
JP2019108357A (ja) 2019-07-04
JP2021073321A (ja) 2021-05-13
EP2968529B1 (en) 2020-08-05
NL301236I2 (nl) 2025-07-31
BR112015021756A2 (pt) 2017-07-18
US20140271836A1 (en) 2014-09-18
WO2014159607A1 (en) 2014-10-02
AU2022201858B2 (en) 2024-04-04

Similar Documents

Publication Publication Date Title
SI2968529T1 (sl) Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo
IL274024A (en) Oral preparations
IL245855A0 (en) Oral formulations of pyrrolidine derivatives
IL240797A0 (en) Defrasirox preparations for oral administration
GB201401248D0 (en) Method of manufacture
IL243268A0 (en) Aids for positioning the heads of premature babies
ZA201602198B (en) Preparation of hydroxy-benzylbenzene derivatives
ZA201505830B (en) Formulations of organc compounds
IL245700A0 (en) Compositions for oral care
PL2967110T3 (pl) Przekąski w postaci gumy do żucia oraz sposoby ich wytwarzania
LT3071191T (lt) Lėto atpalaidavimo kietos geriamosios kompozicijos
GB201305231D0 (en) Method of Manufacture
IL240557A0 (en) Formulations of laquinimod for transdermal administration
GB201305103D0 (en) An oral dosage form
ZA201600408B (en) Formulation of metaxalone
SG11201604136PA (en) Improved formulations for virosomes
TH1501001055A (th) ชิ้นสอดช่องปาก
IL240741A0 (en) Preparations for oral care
GB201311291D0 (en) Method of manufacture
GB201301262D0 (en) Method of manufacture